New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For A;R;SPW;SNY;WBMD;CVS;ESV;TER;BSX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
May 3, 2015
19:18 EDTCVSWalgreens CEO considering offer for Omnicare, Sunday Times says
Walgreens (WBA) CEO Stefano Pessina is considering making an offer for Omnicare (OCR), reports The Sunday Times, citing senior sources. The process is at an early stage, cautioned the sources. The report notes that CVS (CVS) and Express Scripts (ESRX) have also expressed interest.Reference Link
May 1, 2015
16:19 EDTCVSOn The Fly: Top stock stories for Friday
Subscribe for More Information
13:40 EDTBSXBoston Scientific suspends share buyback for next 12-18 months
Subscribe for More Information
13:34 EDTBSXBoston Scientific sees new devices expanding profit margins, Bloomberg says
Boston Scientific sees cost cutting plans and manufacturing new devices more efficiently as helping the company to boost operating profits beyond the 25% goal set for 2017, says Bloomberg. Reference Link
10:00 EDTSPWOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: CVR Refining (CVRR) upgraded to Neutral from Underperform at Credit Suisse... Cash America (CSH) upgraded to Outperform from Market Perform at JMP Securities... Chipotle (CMG) upgraded on positive catalysts at BMO Capital... Cypress Semiconductor (CY) upgraded to Strong Buy from Buy at Needham... Energy Transfer Equity (ETE) upgraded to Strong Buy from Outperform at Raymond James... Expedia (EXPE) upgraded to Outperform from Sector Perform at RBC Capital... Immersion (IMMR) upgraded to Buy from Hold at Ascendiant... Integra LifeSciences (IART) upgraded to Outperform from Market Perform at Wells Fargo... Key Energy (KEG) upgraded to Neutral from Reduce at Global Hunter... Limelight Networks (LLNW) upgraded to Buy from Neutral at B. Riley... Live Nation (LYV) upgraded followin strong core results at Stifel... Mosaic (MOS) upgraded to Outperform from Sector Perform at RBC Capital... Ocwen (OCN) upgraded to Buy from Neutral at Sterne Agee CRT... Pacific Biosciences (PACB) upgraded to Outperform from Market Perform at William Blair... Pinnacle Financial (PNFP) upgraded to Buy from Hold at Sandler O'Neill... SPX Corp. (SPW) upgraded to Overweight from Neutral at JPMorgan... Titan International (TWI) upgraded to Buy from Hold at Feltl... Ultra Petroleum (UPL) upgraded to Market Perform from Underperform at Raymond James... United Insurance (UIHC) upgraded to Outperform from Market Perform at Keefe Bruyette... Western Union (WU) upgraded to Outperform from Market Perform at Wells Fargo... Zayo Group (ZAYO) upgraded to Strong Buy from Outperform at Raymond James.
09:12 EDTCVSOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Ocwen Financial (OCN), up 13.7%... Century Aluminum (CENX), Expedia (EXPE), up 6.1%... FireEye (FEYE), up 5.6%... Agnico Eagle Mines (AEM), up 3%... Gilead Sciences (GILD), up 2.9%... CVS Health (CVS), up 1.4%. ALSO HIGHER: EnerNOC (ENOC), up 26.5% after announcing collaboration with Tesla (TSLA)... Tesla up 1.2% after announcing Tesla Energy and partnerships... Cyberark (CYBR), up 2.9% after FireEye reported quarterly results... Cyberark (CY), up 2.5% after being upgraded to Strong Buy from Buy at Needham. DOWN AFTER EARNINGS: LinkedIn (LNKD), down 19.2%... Pixelworks (PXLW), down 7.5%... Cooper Tire (CTB), down 6.2%... JDS Uniphase (JDSU), down 3.2%... First Solar (FSLR), down 2.4%. ALSO LOWER: Tetralogic (TLOG), down 10.3% after 6.25M share Spot Secondary priced at $4.00.
08:53 EDTCVSCVS Health sees biosimilars to behave more like brands than traditional generics
CVS noted that the first biosimilar approval is just the beginning of approvals that could "unlock additional savings and provide options to clients." For the foreseeable future, CVS said it expects biosimilars to behave more like brands than traditional generics and the company expects to employ its formulary strategies to generate savings for its clients.
08:52 EDTCVSCVS Health sees FY15 free cash flow $5.9B-$6.2B
Subscribe for More Information
08:49 EDTCVSCVS Health sees Q2 adjusted EPS $1.17-$1.20, consensus $1.25
Subscribe for More Information
08:46 EDTCVSCVS Health sees FY15 revenue growth of 7%-8.25%
Subscribe for More Information
08:42 EDTCVSCVS Health says 2016 selling season 'off to a good start'
Updating on the 2015 selling season, CVS reported gross wins of $7.5B and net wins of $4.1B, both up about $500M from its last earnings update. The increases were driven primarily by growth in membership within some health plan clients as well as some additional wins. Regarding the 2016 season, CVS said it has completed about a third of client renewals, which is typical this time of year. CVS added that it remains "well-positioned to provide differentiated products and services that generate savings" for clients, which is "resonating strongly in the market." Comments from the company's earnings call and associated slides.
07:58 EDTBSXBoston Scientific sees FY17-FY19 adjusted EPS to see double digit growth
Sees FY17-FY10 operational revenue to see upside from potential M&A. Sees FY17 organic revenue growth up 3%-5% and FY17 adjusted operation margin up 25%. Sees FY18-FY19 operational revenue growth up 3%-7% and FY18-FY19 adjusted operation margin 50-100 bps annually.
07:56 EDTBSXBoston Scientific sees FY16 double digit growth in adjusted EPS, consensus $1.02
Subscribe for More Information
07:55 EDTBSXBoston Scientific backs FY15 adjusted EPS 88c-92c, consensus 90c
Subscribe for More Information
07:43 EDTSNYExpensive drugs drove over 25% of 2013 Medicare drug spending, WSJ says
Subscribe for More Information
07:04 EDTCVSCVS Health opened 38 new retail drugstores and closed 10 retail drugstores
Subscribe for More Information
07:03 EDTCVSCVS Health reports Q1 Pharmacy Services revenue up 18.2% to $23.9B
Subscribe for More Information
07:02 EDTCVSCVS Health sees Q1 adjusted EPS $1.17-$1.20, consensus $1.25
Subscribe for More Information
07:02 EDTCVSCVS Health narrows FY15 adjusted EPS to $5.08-$5.19 from $5.05-$5.19
FY15 EPS consensus of $5.16. Backs FY15 free cash flow of $5.9B-$6.2B. Backs FY15 cash flow from operations $7.6B-$7.9B.
07:01 EDTCVSCVS Health reports Q1 adjusted EPS $1.14, consensus $1.08
Subscribe for More Information
06:50 EDTSPWSPX Corp. upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded SPX Corp. to Overweight saying fundamental risks are more than discounted in the stock following the recent underperformance. The firm raised its price target for shares to $90 from $83 to reflect its sum-of-the-parts valuation.
April 30, 2015
17:17 EDTTERTeradyne sees Q2 adjusted EPS 42c-48c, consensus 35c
Subscribe for More Information
17:16 EDTTERTeradyne reports Q1 adjusted EPS 17c, consensus 12c
Subscribe for More Information
15:01 EDTCVSNotable companies reporting before tomorrow's open
Subscribe for More Information
15:01 EDTTERNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Visa (V), consensus 62c... Gilead Sciences (GILD), consensus $2.32... American International (AIG), consensus $1.19... Public Storage (PSA), consensus $1.93... LinkedIn (LNKD), consensus 56c... BioMarin Pharmaceutical (BMRN), consensus (53c)... Expedia (EXPE), consensus 9c... Skyworks Solutions (SWKS), consensus $1.13... FleetCor (FLT), consensus $1.40... Eastman Chemical (EMN), consensus $1.60... Western Union (WU), consensus 38c... Fluor (FLR), consensus 98c... Fortune Brands Home & Security (FBHS), consensus 32c... Envision Healthcare (EVHC), consensus 26c... Agnico Eagle Mines (AEM), consensus 10c... FireEye (FEYE), consensus (51c)... Trimble Navigation (TRMB), consensus 30c... PerkinElmer (PKI), consensus 46c... Genpact (G), consensus 25c... athenahealth (ATHN), consensus 14c... Seattle Genetics (SGEN), consensus (19c)... HEALTHSOUTH (HLS), consensus 56c... Teradyne (TER), consensus 12c... Superior Energy (SPN), consensus (5c)... Eldorado Gold (EGO), consensus 2c... Regal Entertainment (RGC), consensus 12c... JDS Uniphase (JDSU), consensus 9c... MRC Global (MRC), consensus 18c... Boyd Gaming (BYD), consensus 9c... Ruckus Wireless (RKUS), consensus 8c... Cloud Peak Energy (CLD), consensus (12c).
14:27 EDTCVSOmnicare attracts interest from CVS Health, Express Scripts, Bloomberg says
Omnicare (OCR) is attracting interest from Express Scripts (ESRX), and CVS (CVS), with other potential buyers including Walgreens Boots Alliance (WBA) and McKesson (MKC), Bloomberg reports, citing people with knowledge of the matter. Initial bids are due in May. Reference Link
14:12 EDTCVSOmnicare said to attract interest from CVS Health Express Scripts
Subscribe for More Information
08:49 EDTBSXBoston Scientific collaborates with MedAxiom and TogetherMD
Subscribe for More Information
05:41 EDTSNYSanofi sees FY15 business EPS to be stable to slightly growing vs. 2014
The positive currency impact on 2015 full-year business EPS is estimated to be approximately 12%, under the assumption that exchange rates remain stable in the following three quarters at the average rates of March 2015.
05:40 EDTSNYSanofi reports Q1 business EPS 1.32 vs. EUR 1.17 last year
Subscribe for More Information
April 29, 2015
17:33 EDTESVEnsco reports Q1 adjusted continuing ops EPS $1.49, consensus $1.29
Subscribe for More Information
17:29 EDTSPWRelational Investors lowers stake in SPX Corp. to 4.9% from 7.07%
15:00 EDTESVNotable companies reporting before tomorrow's open
Subscribe for More Information
10:08 EDTRHigh option volume stocks
High option volume stocks: IG R CLNE BWLD XPO RCII MDRX EXP OTEX BRFS
10:00 EDTROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Capital Agency (AGNC) downgraded at UBS... American Public Education (APEI) downgraded to Hold from Buy at Deutsche Bank... Annaly Capital (NLY) downgraded at UBS... C.H. Robinson (CHRW) downgraded to Neutral from Buy at BofA/Merrill... Church & Dwight (CHD) downgraded to Perform from Outperform at Oppenheimer... Cobalt (CIE) downgraded to Hold from Accumulate at Tudor Pickering... Compass Minerals (CMP) downgraded to Neutral from Overweight at JPMorgan... Corning (GLW) downgraded to Sell from Underperform at CLSA... Corporate Office Properties (OFC) downgraded at Stifel... Entergy (ETR) downgraded to Market Perform from Outperform at BMO Capital... First Interstate (FIBK) downgraded to Market Perform from Outperform at Wells Fargo... German American Bancorp (GABC) downgraded to Market Perform at Keefe Bruyette... IGI Laboratories (IG) downgraded to Market Perform from Outperform at Avondale... Lumber Liquidators (LL) downgraded at Longbow... Marvell (MRVL) downgraded at JMP Securities... National Oilwell (NOV) downgraded to Underweight from Equal Weight at Morgan Stanley... Oceaneering (OII) downgraded to Neutral from Buy at Sterne Agee CRT... OpenText (OTEX) downgraded to Sector Performer from Outperformer at CIBC... Parker-Hannifin (PH) downgraded on macro headwinds at Stifel... Pfizer (PFE) downgraded to Neutral from Buy at Citigroup... Procter & Gamble (PG) downgraded to Hold from Buy at Societe Generale... RTI International (RTI) downgraded to Market Perform from Outperform at FBR Capital... Ryder (R) downgraded to Neutral from Buy at Goldman... Stratasys (SSYS) downgraded to Neutral from Buy at Goldman... Targa Resources (TRGP) downgraded to Accumulate from Buy at Global Hunter... Total System (TSS) downgraded to Market Perform from Outperform at Wells Fargo... Twitter (TWTR) downgraded to Equal Weight from Overweight at Barclays... Wynn Resorts (WYNN) downgraded to Neutral at Susquehanna.
09:16 EDTCVSCVS announces new clinical affiliations with Louisiana, Mississippi organization
Subscribe for More Information
07:12 EDTCVSCVS Health volatility elevated into Q1 and outlook
Subscribe for More Information
06:40 EDTSPWSPX Corp. sees FY15 revenue down 6%-10%
Subscribe for More Information
06:38 EDTSPWSPX Corp. reports Q1 EPS with-items (17c), may not compare to consensus 8c
Reports Q1 revenue $946.9M, consensus $982.61M. Q1 results included 22c per share of costs associated with the planned spin-off of the Flow business.
05:46 EDTRGoldman lowers Trucking sector to Neutral from Attractive
Goldman Sachs downgraded the Trucking sector to Neutral from Attractive citing increased uncertainty around demand. Goldman expects the rising value of the U.S. dollar and spending cuts at energy companies to continue weighing on industrial production. It also points out that spot pricing momentum has slowed. Along with the sector, Goldman cut Ryder (R) to Neutral from Buy. The firm reiterates Old Dominion (ODFL) as its top pick in the Trucking space with a Buy rating and $85 price target. Goldman keeps Neutral ratings on C.H. Robinson (CHRW), Con-way (CNW) and J.B. Hunt (JBHT) and a Sell rating on Landstar System (LSTR).
05:38 EDTRRyder downgraded to Neutral from Buy at Goldman
Subscribe for More Information
April 28, 2015
11:52 EDTBSXBoston Scientific to pay $119M to resolve 2,970 product liability claims
Subscribe for More Information
11:25 EDTBSXBoston Scientific to host investor day
Subscribe for More Information
07:05 EDTBSXBoston Scientific sees Q2 adjusted EPS 20c-22c, consensus 22c
Subscribe for More Information
07:05 EDTBSXBoston Scientific backs FY15 adjusted EPS 88c-92c, consensus 91c
Cuts FY15 revenue to $7.23B-$7.38B from $7.3B-$7.5B, consensus $7.43B.
07:04 EDTBSXBoston Scientific reports Q1 Cardiovascular revenue up 10% to $712M
Reports Q1 Rhythm Management revenue up 4% to $514M; Reports Q1 MedSurg revenue up 4% to $542M.
07:02 EDTBSXBoston Scientific reports Q1 adjusted EPS 21c, consensus 21c
Reports Q1 revenue $1.77B, consensus $1.78B
05:51 EDTBSXBoston Scientific drug Eluvia trial meets primary endpoint
Subscribe for More Information
05:30 EDTSNYGenzyme says FDA grants fast track designation for development of GZ/SAR402671
Genzyme, a Sanofi company, announced that the FDA has granted Fast Track designation for the development of GZ/SAR402671, a new investigational oral substrate reduction therapy for the treatment of Fabry disease. FDAs Fast Track Drug Development Program is designed to facilitate frequent interactions with the FDA review team to expedite the clinical development and review of a New Drug Application, or NDA, for medicines with the potential to treat serious or life-threatening conditions and address unmet medical needs for such disease or conditions. It also provides the opportunity to submit sections of an NDA on a rolling basis before a sponsor submits the complete application. Genzyme is currently enrolling patients in its Phase 2a trial of GZ/SAR402671, and plans to enroll nine treatment-nave male adult patients with Fabry disease in this international, multicenter study.
April 27, 2015
16:23 EDTBSXBoston Scientific announces strategic collaboration with Brainlab AG
Subscribe for More Information
15:04 EDTBSXNotable companies reporting before tomorrow's open
Subscribe for More Information
06:19 EDTSNYPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 23, 2015
13:16 EDTCVSPharmacies, PBMs seen as potential buyers after Omnicare said to explore sale
Subscribe for More Information
12:08 EDTCVSLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Larsen, along with Mary Ptacek, VP of Pharmaceutical Strategies Group and Ruth Krystopolski, EVP of Sanford Health, discuss the 2016-2017 Pharmacy Benefit Managers selling season and which PBMs are poised to gain share, the impact of WBAs growth plans, recent M&A activity and biosimilars on an Analyst/Industry conference call to be held on April 24 at 2 pm.
11:02 EDTAAgilent announces strategic collaboration with National University of Singapore
Subscribe for More Information
10:00 EDTESVOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ADTRAN (ADTN) downgraded to Hold from Buy at Needham... Angie's List (ANGI) downgraded to Underperform from Market Perform at Northland... BG Group (BRGYY) downgraded to Hold from Overweight at HSBC... Brink's (BCO) downgraded to Neutral, sees 'imminent' downside risk, says Macquarie... Citrix (CTXS) downgraded to Hold from Buy at Evercore ISI... Cognex (CGNX) downgraded to Perform from Outperform at Oppenheimer... Cytec Industries (CYT) downgraded to Equal-Weight from Overweight at First Analysis... Enbridge (ENB) downgraded to Neutral from Outperform at Credit Suisse... Ensco (ESV) downgraded to Underweight from Equal Weight at Morgan Stanley... F5 Networks (FFIV) downgraded to Neutral from Buy at MKM Partners... Fulton Financial (FULT) downgraded to Market Perform from Outperform at Keefe Bruyette... Halcon Resources (HK) downgraded to Neutral from Outperform at Baird... Heartland Express (HTLD) downgraded on limited earnings growth at Raymond James... Informatica (INFA) downgraded to Market Perform from Outperform at JMP Securities... Knight Transportation (KNX) downgraded to Outperform from Strong Buy at Raymond James... LegacyTexas Financial (LTXB) downgraded to Outperform from Strong Buy at Raymond James... Masco (MAS) downgraded to Neutral from Buy at Citigroup... MobileIron (MOBL) downgraded to Equal Weight from Overweight at Morgan Stanley... Noble Corp. (NE) downgraded to Underweight from Equal Weight at Morgan Stanley... Omnicare (OCR) downgraded to Neutral from Outperform at Credit Suisse... Owens Corning (OC) downgraded to Sell from Neutral at Citigroup... Qualcomm (QCOM) downgraded to Neutral from Outperform at Exane BNP Paribas... RAM Energy (RAME) downgraded to Neutral from Outperform at Baird... Repsol (REPYY) downgraded to Reduce from Hold at HSBC... Stillwater Mining (SWC) downgraded on lack of catalysts at BB&T... Texas Capital (TCBI) downgraded to Outperform from Strong Buy at Raymond James... Texas Instruments (TXN) downgraded to Neutral from Buy at BofA/Merrill... Total (TOT) downgraded to Hold from Buy at Deutsche Bank... Transocean (RIG) downgraded to Underweight from Equal Weight at Morgan Stanley.
07:35 EDTRRyder reported strong results, says RBC Capital
Subscribe for More Information
06:54 EDTESVEnsco downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley downgraded Ensco to Underweight and lowered its price target to $27.50 from $31.50 based on limited upside, and ENSCO 8500 Series and later cycle recovery exposure.
April 22, 2015
16:15 EDTAAgilent announces resolution to FDA warning letter for Dako Denmark
Subscribe for More Information
10:28 EDTCVSCVS Health April weekly call activity attributed to takeover chatter
Subscribe for More Information
10:02 EDTSNYOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alcatel-Lucent (ALU) upgraded on post-merger outlook at Bernstein... Amazon.com (AMZN) upgraded to Buy, price target raised to $450 at Monness Crespi... BNP Paribas (BNPQY) upgraded to Overweight from Equal Weight at Morgan Stanley... Dolby (DLB) upgraded to Overweight from Neutral at JPMorgan... First Defiance (FDEF) upgraded to Outperform from Market Perform at Raymond James... Gran Tierra (GTE) upgraded to Buy from Neutral at Dundee... Grupo Aval (AVAL) upgraded to Buy from Neutral at Goldman... Manhattan Associates (MANH) upgraded to Buy from Hold at Benchmark Co.... Marriott (MAR) upgraded to Buy from Neutral at MKM Partners... Masco (MAS) upgraded to Outperform from Market Perform at FBR Capital... Nokia (NOK) upgraded on post-merger outlook at Bernstein... Packaging Corp. (PKG) upgraded to Buy from Hold at Deutsche Bank... Rayonier (RYN) upgraded to Sector Perform from Underperform at RBC Capital... Rogers Communications (RCI) upgraded to Buy from Neutral at BofA/Merrill... Sanofi (SNY) upgraded to Neutral from Sell at Citigroup... Select Comfort (SCSS) upgraded to Outperform from Neutral at Wedbush... UniCredit (UNCFF) upgraded to Buy from Sell at Berenberg... Zions Bancorp (ZION) upgraded to Outperform from Market Perform at FBR Capital.
07:57 EDTRRyder sees Q2 EPS $1.58-$1.63, consensus $1.65
Q2 guidance includes some anticipated higher insurance-related costs in Ryder's Dedicated Transportation Solutions business, the company noted.
07:57 EDTRRyder sees FY15 gross CapEx $2.63B, up from prior view fo $2.55B
Subscribe for More Information
07:56 EDTRRyder raises FY15 comparable EPS view to $6.40-$6.55, consensus $6.37
Subscribe for More Information
07:56 EDTRRyder reports Q1 comparable cont ops EPS $1.08, consensus $1.00
Reports Q1 revenue $1.6B, consensus $1.63B.
07:07 EDTSNYEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.
06:52 EDTSNYSanofi upgraded to Neutral from Sell at Citigroup
Subscribe for More Information
April 21, 2015
15:28 EDTRNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Coca-Cola (KO), consensus 42c... Boeing (BA), consensus $1.81... McDonald's (MCD), consensus $1.06... EMC (EMC), consensus 36c... Abbott Laboratories (ABT), consensus 42c... Thermo Fisher Scientific (TMO), consensus $1.61... Bank of New York Mellon (BK), consensus 59c... TE Connectivity (TEL), consensus $1.01... T. Rowe Price Group (TROW), consensus $1.14... St. Jude Medical (STJ), consensus 91c... Amphenol (APH), consensus 56c... Nielsen (NLSN), consensus 47c... Citizens Financial Group (CFG), consensus 34c... Autoliv (ALV), consensus $1.31... D.R. Horton (DHI), consensus 38c... Westinghouse Air Brake Technologies (WAB), consensus 95c... Huntington Bancshares (HBAN), consensus 19c... SEI Investments (SEIC), consensus 49c... AutoNation (AN), consensus 89c... Gentex (GNTX), consensus 25c... Ryder System (R), consensus $1.00... Owens Corning (OC), consensus 13c... NuStar Energy (NS), consensus 58c... Six Flags (SIX), consensus (67c)... Tupperware Brands (TUP), consensus 98c... MarketAxess Holdings (MKTX), consensus 64c... Lithia Motors (LAD), consensus $1.22... Knight Transportation (KNX), consensus 31c... Evercore Partners (EVR), consensus 58c... Potlatch (PCH), consensus 19c... Natus Medical (BABY), consensus 29c... AZZ (AZZ), consensus 59c... United Community Banks (UCBI), consensus 29c... Sonus Networks (SONS), consensus (31c)... Angie's List (ANGI), consensus 0c... Pacific Premier Bancorp (PPBI), consensus 27c.
09:01 EDTSNYGenzyme initiates Phase 2a trial to evaluate pharmocodynamics of GZ/SAR402671
Subscribe for More Information
08:51 EDTAJPMorgan life sciences analyst holds an analyst/industry conference call
Subscribe for More Information
April 20, 2015
17:20 EDTSPWRelational Investors lowers stake in SPX Corp. to 5.77% from 7.07%
16:09 EDTBSXBoston Scientific announces long-term data underscore safety, efficacy of S-ICD
The Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific S-ICD System for patients at risk of sudden cardiac arrest. The study, "Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-year Results from a Pooled Analysis of the IDE Study and EFFORTLESS Registry" was led by Dr. Martin Burke, professor of medicine at the University of Chicago. The analysis combined data from two large S-ICD studies to provide the most comprehensive look at S-ICD System patient outcomes to date. The all-cause mortality rate for the S-ICD patients was 1.6% per year, comparing favorably to observed mortality rates in similar TV-ICD studies. Currently, the S-ICD System is covered nationally by Medicare, Aetna, Cigna and others, and regionally by numerous private and Medicaid plans, providing coverage for approximately 170M individuals in the U.S. The S-ICD System has been commercially available in Europe since 2009.
09:20 EDTSNYLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information
07:44 EDTBSXSurvey shows strong momentum for Boston Scientific devices, says RBC Capital
RBC Capital says that its survey supports strong momentum for Boston Scientific's S-ICD and Watchman, and the firm thinks the company is probably gaining share in single-chamber ICDs. The firm raised its price target on the shares to $20 from $17 and recommends buying the shares at current levels or on pullbacks.
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use